Translational Psychiatry

Papers
(The TQCC of Translational Psychiatry is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Resilience, COVID-19-related stress, anxiety and depression during the pandemic in a large population enriched for healthcare providers396
Psychological health, sleep quality, and coping styles to stress facing the COVID-19 in Wuhan, China242
Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer’s disease203
Epidemiology of mental health problems among patients with cancer during COVID-19 pandemic188
Common and distinct patterns of intrinsic brain activity alterations in major depression and bipolar disorder: voxel-based meta-analysis160
Maternal acute and chronic inflammation in pregnancy is associated with common neurodevelopmental disorders: a systematic review159
Mapping global prevalence of depression among postpartum women157
Psychiatric face of COVID-19154
Deep learning in mental health outcome research: a scoping review140
Depression—an underrecognized target for prevention of dementia in Alzheimer’s disease134
A quantitative and qualitative study on the neuropsychiatric sequelae of acutely ill COVID-19 inpatients in isolation facilities122
Psycho-social factors associated with mental resilience in the Corona lockdown121
Multi-trait analysis for genome-wide association study of five psychiatric disorders120
A key role of the subdiaphragmatic vagus nerve in the depression-like phenotype and abnormal composition of gut microbiota in mice after lipopolysaccharide administration120
ENIGMA MDD: seven years of global neuroimaging studies of major depression through worldwide data sharing113
Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder111
Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer’s disease111
Rodent models of post-traumatic stress disorder: behavioral assessment104
Associations between disordered gut microbiota and changes of neurotransmitters and short-chain fatty acids in depressed mice103
Public mental health problems during COVID-19 pandemic: a large-scale meta-analysis of the evidence100
Depression, anxiety and associated factors among Chinese adolescents during the COVID-19 outbreak: a comparison of two cross-sectional studies96
Blood-brain barrier associated tight junction disruption is a hallmark feature of major psychiatric disorders94
Evidence-based umbrella review of 162 peripheral biomarkers for major mental disorders93
Oxidative stress marker aberrations in children with autism spectrum disorder: a systematic review and meta-analysis of 87 studies (N = 9109)79
How machine-learning recommendations influence clinician treatment selections: the example of antidepressant selection78
Systematic review and meta-analysis: effects of maternal separation on anxiety-like behavior in rodents77
Computer vision in autism spectrum disorder research: a systematic review of published studies from 2009 to 201976
Impact of COVID-19 lockdown on mental health in Germany: longitudinal observation of different mental health trajectories and protective factors76
Mild behavioral impairment and its relation to tau pathology in preclinical Alzheimer’s disease75
Antidepressants fluoxetine and amitriptyline induce alterations in intestinal microbiota and gut microbiome function in rats exposed to chronic unpredictable mild stress72
The prevalence of psychiatric symptoms of pregnant and non-pregnant women during the COVID-19 epidemic72
Machine-learning classification using neuroimaging data in schizophrenia, autism, ultra-high risk and first-episode psychosis70
A systematic review of childhood maltreatment and DNA methylation: candidate gene and epigenome-wide approaches70
Neuronal hyperexcitability in Alzheimer’s disease: what are the drivers behind this aberrant phenotype?68
Mental disorders following COVID-19 and other epidemics: a systematic review and meta-analysis67
Short-term metreleptin treatment of patients with anorexia nervosa: rapid on-set of beneficial cognitive, emotional, and behavioral effects67
Genetics of structural and functional brain changes in autism spectrum disorder63
Recovering from depression with repetitive transcranial magnetic stimulation (rTMS): a systematic review and meta-analysis of preclinical studies61
Efficacy and safety of clozapine in psychotic disorders—a systematic quantitative meta-review59
Role of diet and its effects on the gut microbiome in the pathophysiology of mental disorders59
Transdiagnostic dimensions of psychopathology explain individuals’ unique deviations from normative neurodevelopment in brain structure57
Machine learning for suicide risk prediction in children and adolescents with electronic health records57
America’s opioid crisis: the need for an integrated public health approach57
Single-cell mass cytometry of microglia in major depressive disorder reveals a non-inflammatory phenotype with increased homeostatic marker expression56
Acute psychological effects of Coronavirus Disease 2019 outbreak among healthcare workers in China: a cross-sectional study56
Tauopathy in the young autistic brain: novel biomarker and therapeutic target56
Biallelic mutations in the death domain of PIDD1 impair caspase-2 activation and are associated with intellectual disability55
Catalpol ameliorates depressive-like behaviors in CUMS mice via oxidative stress-mediated NLRP3 inflammasome and neuroinflammation55
Association between sedentary behavior and the risk of dementia: a systematic review and meta-analysis54
Common genetic risk variants identified in the SPARK cohort support DDHD2 as a candidate risk gene for autism54
N,N-dimethyltryptamine compound found in the hallucinogenic tea ayahuasca, regulates adult neurogenesis in vitro and in vivo54
Cerebrospinal fluid, antineuronal autoantibody, EEG, and MRI findings from 992 patients with schizophreniform and affective psychosis54
Neuroinflammation in schizophrenia: the role of nuclear factor kappa B54
Altered resting-state functional connectome in major depressive disorder: a mega-analysis from the PsyMRI consortium53
Gut microbiota link dietary fiber intake and short-chain fatty acid metabolism with eating behavior53
A randomised, double-blind, sham-controlled trial of deep brain stimulation of the bed nucleus of the stria terminalis for treatment-resistant obsessive-compulsive disorder53
Probiotics-induced changes in gut microbial composition and its effects on cognitive performance after stress: exploratory analyses52
The association between depression and metabolic syndrome and its components: a bidirectional two-sample Mendelian randomization study52
Activation of BDNF by transcription factor Nrf2 contributes to antidepressant-like actions in rodents51
A randomized, double-blind, active placebo-controlled study of efficacy, safety, and durability of repeated vs single subanesthetic ketamine for treatment-resistant depression51
Whole-blood expression of inflammasome- and glucocorticoid-related mRNAs correctly separates treatment-resistant depressed patients from drug-free and responsive patients in the BIODEP study50
Association between DNA methylation and ADHD symptoms from birth to school age: a prospective meta-analysis50
The type of stress matters: repeated injection and permanent social isolation stress in male mice have a differential effect on anxiety- and depressive-like behaviours, and associated biological alter49
Plasma lipidome is dysregulated in Alzheimer’s disease and is associated with disease risk genes49
Gray and white matter morphology in substance use disorders: a neuroimaging systematic review and meta-analysis49
Gut microbial taxa elevated by dietary sugar disrupt memory function49
Mindfulness practice for protecting mental health during the COVID-19 pandemic49
Dopamine regulates pancreatic glucagon and insulin secretion via adrenergic and dopaminergic receptors49
Characterization of gut microbiome in mice model of depression with divergent response to escitalopram treatment48
Basal and LPS-stimulated inflammatory markers and the course of individual symptoms of depression47
Clinical, gut microbial and neural effects of a probiotic add-on therapy in depressed patients: a randomized controlled trial47
Parental characteristics and offspring mental health and related outcomes: a systematic review of genetically informative literature46
Establishing a clinical service to prevent psychosis: What, how and when? Systematic review46
Network analysis of depressive and anxiety symptoms in adolescents during the later stage of the COVID-19 pandemic46
Designing m-Health interventions for precision mental health support46
EEG microstates as biomarker for psychosis in ultra-high-risk patients46
Modeling alcohol-induced neurotoxicity using human induced pluripotent stem cell-derived three-dimensional cerebral organoids46
Neurogranin as a cognitive biomarker in cerebrospinal fluid and blood exosomes for Alzheimer’s disease and mild cognitive impairment46
Prenatal stress causes intrauterine inflammation and serotonergic dysfunction, and long-term behavioral deficits through microbe- and CCL2-dependent mechanisms46
Glutamate and microglia activation as a driver of dendritic apoptosis: a core pathophysiological mechanism to understand schizophrenia45
Reducing intrusive memories after trauma via a brief cognitive task intervention in the hospital emergency department: an exploratory pilot randomised controlled trial45
Structural and functional deficits and couplings in the cortico-striato-thalamo-cerebellar circuitry in social anxiety disorder45
Spontaneous and deliberate creative cognition during and after psilocybin exposure45
Ventromedial prefrontal cortex/anterior cingulate cortex Glx, glutamate, and GABA levels in medication-free major depressive disorder45
Meta-analysis of probability estimates of worldwide variation of CYP2D6 and CYP2C1945
“GrimAge,” an epigenetic predictor of mortality, is accelerated in major depressive disorder44
Structural neuroimaging biomarkers for obsessive-compulsive disorder in the ENIGMA-OCD consortium: medication matters44
Non-invasive brain stimulation for posttraumatic stress disorder: a systematic review and meta-analysis44
Psychological and biological resilience modulates the effects of stress on epigenetic aging43
Worldwide prevalence of suicidal ideation and suicide plan among people with schizophrenia: a meta-analysis and systematic review of epidemiological surveys43
Neurosteroid allopregnanolone (3α,5α-THP) inhibits inflammatory signals induced by activated MyD88-dependent toll-like receptors43
Alterations in acylcarnitines, amines, and lipids inform about the mechanism of action of citalopram/escitalopram in major depression43
COVID-19 and risk of neurodegenerative disorders: A Mendelian randomization study43
A randomized placebo-controlled PET study of ketamine´s effect on serotonin1B receptor binding in patients with SSRI-resistant depression43
Personalized machine learning of depressed mood using wearables43
Fractionating autism based on neuroanatomical normative modeling42
Capsaicin consumption reduces brain amyloid-beta generation and attenuates Alzheimer’s disease-type pathology and cognitive deficits in APP/PS1 mice42
Using polygenic scores for identifying individuals at increased risk of substance use disorders in clinical and population samples42
A systematic review and narrative synthesis of data-driven studies in schizophrenia symptoms and cognitive deficits42
Alterations of multiple peripheral inflammatory cytokine levels after repeated ketamine infusions in major depressive disorder42
Decelerated epigenetic aging associated with mood stabilizers in the blood of patients with bipolar disorder41
ARHGAP10, which encodes Rho GTPase-activating protein 10, is a novel gene for schizophrenia risk41
Melatonin’s neuroprotective role in mitochondria and its potential as a biomarker in aging, cognition and psychiatric disorders41
A machine learning algorithm to differentiate bipolar disorder from major depressive disorder using an online mental health questionnaire and blood biomarker data41
Insulinopathies of the brain? Genetic overlap between somatic insulin-related and neuropsychiatric disorders41
A diet high in sugar and fat influences neurotransmitter metabolism and then affects brain function by altering the gut microbiota41
Genome-wide association study of Alzheimer’s disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset41
Sleep in Alzheimer’s disease: a systematic review and meta-analysis of polysomnographic findings41
Gene expression studies in Depression development and treatment: an overview of the underlying molecular mechanisms and biological processes to identify biomarkers41
Anterior insula stimulation suppresses appetitive behavior while inducing forebrain activation in alcohol-preferring rats40
Ergothioneine, a metabolite of the gut bacterium Lactobacillus reuteri, protects against stress-induced sleep disturbances40
Late-life depression and increased risk of dementia: a longitudinal cohort study40
Efficacy and tolerability of repetitive transcranial magnetic stimulation for the treatment of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis40
The association of clinical correlates, metabolic parameters, and thyroid hormones with suicide attempts in first-episode and drug-naïve patients with major depressive disorder comorbid with anxiety: 40
Socioeconomic status, BMI, and brain development in children40
Neuroinflammatory alterations in trait anxiety: modulatory effects of minocycline40
COVID-19 restrictions and age-specific mental health—U.S. probability-based panel evidence40
Long non-coding RNA Neat1 regulates adaptive behavioural response to stress in mice39
Maternal immune conditions are increased in males with autism spectrum disorders and are associated with behavioural and emotional but not cognitive co-morbidity39
Childhood trauma, suicide risk and inflammatory phenotypes of depression: insights from monocyte gene expression39
Transcription factor 4 and its association with psychiatric disorders39
Mechanisms of neuroplasticity linking early adversity to depression: developmental considerations39
Immunological causes of obsessive-compulsive disorder: is it time for the concept of an “autoimmune OCD” subtype?39
Cannabinoid receptor CNR1 expression and DNA methylation in human prefrontal cortex, hippocampus and caudate in brain development and schizophrenia39
Theta burst stimulation for the acute treatment of major depressive disorder: A systematic review and meta-analysis38
Hippocampal glutamate and hippocampus subfield volumes in antipsychotic-naive first episode psychosis subjects and relationships to duration of untreated psychosis38
A neuromarker of individual general fluid intelligence from the white-matter functional connectome38
Functional neural correlates of psychopathy: a meta-analysis of MRI data38
What could we learn from SARS when facing the mental health issues related to the COVID-19 outbreak? A nationwide cohort study in Taiwan38
Network analysis of depressive symptoms in Hong Kong residents during the COVID-19 pandemic38
Dissecting clinical heterogeneity of bipolar disorder using multiple polygenic risk scores38
Genetic variations influence brain changes in patients with attention-deficit hyperactivity disorder38
Machine learning classification of ADHD and HC by multimodal serotonergic data38
Default mode and salience network alterations in suicidal and non-suicidal self-injurious thoughts and behaviors in adolescents with depression38
Influence of social isolation caused by coronavirus disease 2019 (COVID-19) on the psychological characteristics of hospitalized schizophrenia patients: a case-control study38
Integrative analysis of genome-wide association studies identifies novel loci associated with neuropsychiatric disorders38
Effects of early life exposure to traffic-related air pollution on brain development in juvenile Sprague-Dawley rats38
Proteomics analysis of the gut–brain axis in a gut microbiota-dysbiosis model of depression37
Serum d-serine levels are altered in early phases of Alzheimer’s disease: towards a precocious biomarker37
Consolidation/reconsolidation therapies for the prevention and treatment of PTSD and re-experiencing: a systematic review and meta-analysis37
d-Serine as the gatekeeper of NMDA receptor activity: implications for the pharmacologic management of anxiety disorders37
Anxiety and depressive symptoms in college students during the late stage of the COVID-19 outbreak: a network approach37
Accelerated brain aging predicts impaired cognitive performance and greater disability in geriatric but not midlife adult depression37
Anomalous brain gyrification patterns in major psychiatric disorders: a systematic review and transdiagnostic integration37
Enduring neurobehavioral effects induced by microbiota depletion during the adolescent period37
COVID-19 patients managed in psychiatric inpatient settings due to first-episode mental disorders in Wuhan, China: clinical characteristics, treatments, outcomes, and our experiences36
Pairwise common variant meta-analyses of schizophrenia with other psychiatric disorders reveals shared and distinct gene and gene-set associations36
The IL-6 antagonist tocilizumab is associated with worse depression and related symptoms in the medically ill36
Title: “Labels Matter: Is it stress or is it Trauma?”36
Early life adversity shapes neural circuit function during sensitive postnatal developmental periods35
Anomaly detection to predict relapse risk in schizophrenia35
Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study35
Cannabis, schizophrenia genetic risk, and psychotic experiences: a cross-sectional study of 109,308 participants from the UK Biobank35
The role of the immune system in posttraumatic stress disorder35
The role of social cognition skills and social determinants of health in predicting symptoms of mental illness35
Neuropsychiatric manifestations of COVID-19, potential neurotropic mechanisms, and therapeutic interventions35
Alzheimer’s disease-related dysregulation of mRNA translation causes key pathological features with ageing35
Associations of interruptions to leisure-time sedentary behaviour with symptoms of depression and anxiety34
Neural contributors to trauma resilience: a review of longitudinal neuroimaging studies34
Brain dynamics: the temporal variability of connectivity, and differences in schizophrenia and ADHD34
Amyloid-beta uptake by blood monocytes is reduced with ageing and Alzheimer’s disease34
Increased GFAP concentrations in the cerebrospinal fluid of patients with unipolar depression34
Gut microbiota, innate immune pathways, and inflammatory control mechanisms in patients with major depressive disorder34
A schizophrenia subgroup with elevated inflammation displays reduced microglia, increased peripheral immune cell and altered neurogenesis marker gene expression in the subependymal zone34
The patterns of family genetic risk scores for eleven major psychiatric and substance use disorders in a Swedish national sample34
Longitudinal plasma phosphorylated tau 181 tracks disease progression in Alzheimer’s disease34
Gamma oscillations predict pro-cognitive and clinical response to auditory-based cognitive training in schizophrenia34
The efficacy and safety of omega-3 fatty acids on depressive symptoms in perinatal women: a meta-analysis of randomized placebo-controlled trials34
Ethnic and trans-ethnic genome-wide association studies identify new loci influencing Japanese Alzheimer’s disease risk34
Sensory over-responsivity is related to GABAergic inhibition in thalamocortical circuits33
The effects of social isolation stress and discrimination on mental health33
Compassion toward others and self-compassion predict mental and physical well-being: a 5-year longitudinal study of 1090 community-dwelling adults across the lifespan33
Neuregulin 1: an intriguing therapeutic target for neurodevelopmental disorders33
Characteristics of gray matter alterations in never-treated and treated chronic schizophrenia patients33
Social support mediates the influence of cerebellum functional connectivity strength on postpartum depression and postpartum depression with anxiety33
Fronto-limbic neural variability as a transdiagnostic correlate of emotion dysregulation33
Ibudilast, a neuroimmune modulator, reduces heavy drinking and alcohol cue-elicited neural activation: a randomized trial33
MicroRNA-dependent control of neuroplasticity in affective disorders33
Thalamocortical connectivity is associated with autism symptoms in high-functioning adults with autism and typically developing adults32
Impaired mitochondrial complex I function as a candidate driver in the biological stress response and a concomitant stress-induced brain metabolic reprogramming in male mice32
l-DOPA and consolidation of fear extinction learning among women with posttraumatic stress disorder32
Brain structural correlates of insomnia severity in 1053 individuals with major depressive disorder: results from the ENIGMA MDD Working Group32
Antidepressant side effects and their impact on treatment outcome in people with major depressive disorder: an iSPOT-D report32
Magnetic resonance imaging for individual prediction of treatment response in major depressive disorder: a systematic review and meta-analysis32
Intensification of functional neural control on heartbeat dynamics in subclinical depression32
Genome-wide association studies of antidepressant class response and treatment-resistant depression32
Precision psychiatry with immunological and cognitive biomarkers: a multi-domain prediction for the diagnosis of bipolar disorder or schizophrenia using machine learning32
Alterations of kynurenine pathway in alcohol use disorder and abstinence: a link with gut microbiota, peripheral inflammation and psychological symptoms32
Immune response and endocytosis pathways are associated with the resilience against Alzheimer’s disease31
Cytokines and tryptophan metabolites can predict depressive symptoms in pregnancy31
Emerging behavioral and neuroimaging biomarkers for early and accurate characterization of autism spectrum disorders: a systematic review31
Acute psychological impact on COVID-19 patients in Hubei: a multicenter observational study31
Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET status31
Shared polygenic risk for ADHD, executive dysfunction and other psychiatric disorders31
Optimizing prediction of response to antidepressant medications using machine learning and integrated genetic, clinical, and demographic data31
Neuroinflammation mechanisms of neuromodulation therapies for anxiety and depression31
Transcriptome-wide association study identifies new susceptibility genes and pathways for depression31
Genome-wide DNA methylation and gene expression analyses in monozygotic twins identify potential biomarkers of depression30
Hippocampal volume in early psychosis: a 2-year longitudinal study30
Dopamine: from prediction error to psychotherapy30
A simultaneous [11C]raclopride positron emission tomography and functional magnetic resonance imaging investigation of striatal dopamine binding in autism30
Neuroinflammation in dementia with Lewy bodies: a human post-mortem study30
Contributing factors to advanced brain aging in depression and anxiety disorders30
Effects of polygenic risk for Alzheimer’s disease on rate of cognitive decline in normal aging30
Altered anterior cingulate glutamatergic metabolism in depressed adolescents with current suicidal ideation30
An epigenome-wide association study of early-onset major depression in monozygotic twins30
Prevalence of poor psychiatric status and sleep quality among frontline healthcare workers during and after the COVID-19 outbreak: a longitudinal study30
Emerging functional connectivity differences in newborn infants vulnerable to autism spectrum disorders30
Psychobiotic interventions for anxiety in young people: a systematic review and meta-analysis, with youth consultation29
Sex differences in the neuroanatomy of alcohol dependence: hippocampus and amygdala subregions in a sample of 966 people from the ENIGMA Addiction Working Group29
Natural Language Processing markers in first episode psychosis and people at clinical high-risk29
Translational evaluation of novel selective orexin-1 receptor antagonist JNJ-61393215 in an experimental model for panic in rodents and humans29
Role of dietary factors in the prevention and treatment for depression: an umbrella review of meta-analyses of prospective studies29
Zbtb16 regulates social cognitive behaviors and neocortical development29
Level and timing of physical activity during normal daily life in depressed and non-depressed individuals29
Presynaptic dysfunction in CASK-related neurodevelopmental disorders29
Environmental regulation of the chloride transporter KCC2: switching inflammation off to switch the GABA on?29
Low dose oral ketamine treatment in chronic suicidality: An open-label pilot study29
Cortisol and inflammatory biomarker levels in youths with attention deficit hyperactivity disorder (ADHD): evidence from a systematic review with meta-analysis29
Multi-domain potential biomarkers for post-traumatic stress disorder (PTSD) severity in recent trauma survivors29
Exploratory drive, fear, and anxiety are dissociable and independent components in foraging mice29
From mechanisms to markers: novel noninvasive EEG proxy markers of the neural excitation and inhibition system in humans29
Obesity and atypical depression symptoms: findings from Mendelian randomization in two European cohorts29
Functional network alterations differently associated with suicidal ideas and acts in depressed patients: an indirect support to the transition model29
Translational evidence for lithium-induced brain plasticity and neuroprotection in the treatment of neuropsychiatric disorders29
Prevalence of and factors associated with post-traumatic stress disorder among French university students 1 month after the COVID-19 lockdown29
Identification of a novel polymorphism associated with reduced clozapine concentration in schizophrenia patients—a genome-wide association study adjusting for smoking habits28
The proteomic architecture of schizophrenia iPSC-derived cerebral organoids reveals alterations in GWAS and neuronal development factors28
Brain network dysfunctions in addiction: a meta-analysis of resting-state functional connectivity28
Mesenchymal stem cells derived extracellular vesicles improve behavioral and biochemical deficits in a phencyclidine model of schizophrenia28
Genome-wide DNA methylation analysis of heavy cannabis exposure in a New Zealand longitudinal cohort28
Peripheral immune cell reactivity and neural response to reward in patients with depression and anhedonia28
Polygenic overlap and shared genetic loci between loneliness, severe mental disorders, and cardiovascular disease risk factors suggest shared molecular mechanisms28
The prevalence of depressive and anxiety symptoms and their associations with quality of life among clinically stable older patients with psychiatric disorders during the COVID-19 pandemic28
White-matter functional topology: a neuromarker for classification and prediction in unmedicated depression28
A randomised clinical trial of methotrexate points to possible efficacy and adaptive immune dysfunction in psychosis28
Exposure to maternal high-fat diet induces extensive changes in the brain of adult offspring28
Stress induces insertion of calcium-permeable AMPA receptors in the OFC–BLA synapse and modulates emotional behaviours in mice28
Prevalence and correlates of suicidal ideation and suicide attempts in preadolescent children: A US population-based study28
Proteomics of autism and Alzheimer’s mouse models reveal common alterations in mTOR signaling pathway28
Genetic association study of childhood aggression across raters, instruments, and age28
Decentering as a core component in the psychological treatment and prevention of youth anxiety and depression: a narrative review and insight report28
The role of omega-3 fatty acids in preventing glucocorticoid-induced reduction in human hippocampal neurogenesis and increase in apoptosis28
Beyond antipsychotics: a twenty-first century update for preclinical development of schizophrenia therapeutics27
Cell-type-specific expression quantitative trait loci associated with Alzheimer disease in blood and brain tissue27
Volumetric changes in subcortical structures following repeated ketamine treatment in patients with major depressive disorder: a longitudinal analysis27
Cognitive impact of neuronal antibodies: encephalitis and beyond27
Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients27
Default-mode and fronto-parietal network connectivity during rest distinguishes asymptomatic patients with bipolar disorder and major depressive disorder27
The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and magnetic resonance spectroscopy brain imagi27
0.1179211139679